September 2025 Counterfeit & Illicit Drug News Roundup
Counterfeit medicines and illicit drugs remained a global concern throughout September, with cases spanning from fake weight-loss injectables to counterfeit cancer therapies. Governments, regulators, and enforcement agencies issued new warnings, while several high-profile cases underscored the dangers of unregulated products.
Public Warnings & Health Risks
Fake GLP-1 Seizures in the UK – Police are searching for a woman after seizing over £32,000 worth of suspected counterfeit Mounjaro and Ozempic injections, highlighting the growing black market for weight-loss drugs. Pharmacy Magazine
WHO Issues Ozempic Warning – The World Health Organization issued a regional alert about falsified Ozempic circulating in markets, stressing that these injections could pose serious risks to patients. Panorama
Fake Botox Case in Massachusetts – An unlicensed injector allegedly using counterfeit Botox in a med spa was linked to serious health risks, underscoring gaps in oversight of local aesthetic clinics. GBH News
Europe’s Counterfeit Weight-Loss Drug Surge – Regulators across Europe reported a sharp rise in counterfeit versions of Novo Nordisk and Eli Lilly’s blockbuster GLP-1 weight-loss therapies. FiercePharma
Regulators Sound Alarm – A feature report emphasized the dangers of unapproved GLP-1 injectables spreading globally, many purchased online without quality control. The Medicine Maker
Calls for Stronger U.S. Action – An editorial urged U.S. lawmakers to crack down on imports of illegal weight-loss drugs and their ingredients before the market becomes further saturated with counterfeits. SNJ Today
Enforcement & Criminal Cases
Vietnam Counterfeit Cancer Drug Trial – A high-profile case in Vietnam returned to appeals court, involving large-scale smuggling of fake cancer medicines. Báo Nghệ An (EN)
Nigeria Mega-Seizure – Nigerian Customs intercepted 20 containers of illicit drugs and contraband, valued at more than ₦13.5 billion, in Rivers State. The Guardian (Nigeria)
DEA Campus Campaign – In the U.S., the DEA launched a campus awareness campaign in Michigan and Ohio to educate students about counterfeit pill dangers, tying prevention to community outreach. Hoodline
$2M Device Scam Guilty Plea – A Minnesota woman admitted guilt in a $2 million counterfeit medical device scheme, demonstrating how counterfeit risks extend beyond drugs to healthcare hardware. Hoodline
Fentanyl-Laced Pills & Sanctions – The U.S. Treasury sanctioned two Indian nationals accused of distributing counterfeit pills laced with fentanyl, linking the trade to transnational organized crime. Hindustan Times
Policy, Regulation & Government Action
India’s State-Level Response – Uttarakhand’s Chief Minister directed police to crack down on counterfeit medicines while balancing relief priorities after natural disasters. ANI
Delhi Government Testing Results – Authorities in Delhi announced that most “counterfeit cancer drug” samples recently tested were genuine, but stressed vigilance and the need for stronger checks. MSN
Special Anti-Counterfeit Committee – Delhi is also forming a dedicated committee to investigate and prevent fake medicine circulation, signaling stronger institutional responses. The Patriot
Market, Supply & Access Issues
Kenya’s Struggle for Affordable Medicines – The ongoing battle for diabetes and blood-pressure drugs in Kenya reflects both shortages and the risk of counterfeit infiltration. Nation Africa
Drug Traceability Challenges – A critical op-ed argued that India’s current pharmaceutical traceability systems remain inadequate to stop counterfeit circulation. Express Pharma
Anti-Counterfeiting Market Outlook – Analysts predict continued growth for pharmaceutical anti-counterfeiting technologies as companies and regulators push for stronger safeguards. OpenPR
Adulterated Products & Supplements
Hidden Drug in Supplements – A supposedly “natural” product marketed for men was found to contain a hidden erectile dysfunction drug, renewing concerns about supplement adulteration. Yahoo News
Ongoing Coverage
Updates from DrugsControl offered snapshots of regulatory actions and enforcement developments across India this month. Report #43044 | Report #43180
👉 This month’s roundup shows the global spread of counterfeit risks, ranging from local med-spa procedures to cross-border fentanyl pill networks. The consistent theme: demand for high-value drugs (especially GLP-1s) continues to outpace safe supply, creating fertile ground for counterfeiters.